Encision Signs Master Services Agreement with Vicarious Surgical Inc.
Encision Inc. (OTC PINK:ECIA), a medical device company specializing in Active Electrode Monitoring (AEM) Technology, has signed a Master Services Agreement with Vicarious Surgical Inc. The agreement, effective July 8, 2024, involves Encision providing design services for elements of Vicarious' robotic surgical system.
Gregory J. Trudel, President and CEO of Encision, expressed excitement about the collaboration, highlighting the opportunity to bring best-in-class technology to surgical robotics and contribute to patient safety and clinical performance. Encision, based in Boulder, Colorado, focuses on developing surgical instrumentation that enhances patient safety and surgical performance across various minimally invasive procedures.
Encision Inc. (OTC PINK:ECIA), un'azienda di dispositivi medici specializzata nella Tecnologia di Monitoraggio degli Elettrodi Attivi (AEM), ha firmato un Contratto Quadro di Servizi con Vicarious Surgical Inc.. L'accordo, che entra in vigore l'8 luglio 2024, prevede che Encision fornisca servizi di progettazione per elementi del sistema chirurgico robotico di Vicarious.
Gregory J. Trudel, Presidente e CEO di Encision, ha espresso entusiasmo per la collaborazione, sottolineando l'opportunità di portare tecnologia di alta qualità nella chirurgia robotica e di contribuire alla sicurezza dei pazienti e alla performance clinica. Encision, con sede a Boulder, Colorado, si concentra nello sviluppo di strumenti chirurgici che migliorano la sicurezza dei pazienti e le prestazioni chirurgiche in diverse procedure minimamente invasive.
Encision Inc. (OTC PINK:ECIA), una empresa de dispositivos médicos especializada en Tecnología de Monitoreo de Electrodos Activos (AEM), ha firmado un Acuerdo Marco de Servicios con Vicarious Surgical Inc.. El acuerdo, que entra en vigor el 8 de julio de 2024, implica que Encision proporcionará servicios de diseño para elementos del sistema quirúrgico robótico de Vicarious.
Gregory J. Trudel, Presidente y CEO de Encision, expresó su entusiasmo por la colaboración, destacando la oportunidad de llevar tecnología de vanguardia a la cirugía robótica y contribuir a la seguridad del paciente y al rendimiento clínico. Encision, con sede en Boulder, Colorado, se enfoca en desarrollar instrumentos quirúrgicos que mejoran la seguridad del paciente y el rendimiento quirúrgico en varios procedimientos mínimamente invasivos.
Encision Inc. (OTC PINK:ECIA)는 능동 전극 모니터링(AEM) 기술을 전문으로 하는 의료 기기 회사로, Vicarious Surgical Inc.와 서비스 마스터 계약을 체결했습니다. 이 계약은 2024년 7월 8일부터 시행되며, Encision은 Vicarious의 로봇 수술 시스템의 설계 서비스를 제공할 것입니다.
Encision의 회장 겸 CEO인 Gregory J. Trudel은 협업에 대한 기대감을 표명하며 수술 로봇 기술에 최상의 기술을 도입하고 환자 안전과 임상 성과에 기여할 수 있는 기회를 강조했습니다. 콜로라도주 볼더에 본사를 두고 있는 Encision은 다양한 최소 침습 절차에서 환자 안전과 수술 성과를 향상시키는 수술 기구 개발에 중점을 두고 있습니다.
Encision Inc. (OTC PINK:ECIA), une entreprise de dispositifs médicaux spécialisée dans la Technologie de Surveillance des Électrodes Actives (AEM), a signé un Contrat-Cadre de Services avec Vicarious Surgical Inc.. Le contrat, qui entrera en vigueur le 8 juillet 2024, implique qu'Encision fournira des services de conception pour des éléments du système chirurgical robotique de Vicarious.
Gregory J. Trudel, Président et CEO d'Encision, a exprimé son enthousiasme pour cette collaboration, soulignant l'opportunité d'apporter une technologie de pointe à la robotique chirurgicale et de contribuer à la sécurité des patients ainsi qu'à la performance clinique. Encision, basée à Boulder, Colorado, se concentre sur le développement d'instruments chirurgicaux qui améliorent la sécurité des patients et la performance chirurgicale dans diverses procédures peu invasives.
Encision Inc. (OTC PINK:ECIA), ein Unternehmen für medizinische Geräte, das auf Aktive Elektrodenüberwachung (AEM) Technologie spezialisiert ist, hat einen Master-Service-Vertrag mit Vicarious Surgical Inc. unterzeichnet. Der Vertrag, der am 8. Juli 2024 in Kraft tritt, umfasst die Bereitstellung von Entwurfsdienstleistungen für Elemente des robotergestützten chirurgischen Systems von Vicarious durch Encision.
Gregory J. Trudel, Präsident und CEO von Encision, äußerte seine Begeisterung über die Zusammenarbeit und hob die Möglichkeit hervor, spitzenmäßige Technologie in die chirurgische Robotik einzubringen und zur Patientensicherheit sowie zur klinischen Leistungsfähigkeit beizutragen. Encision mit Sitz in Boulder, Colorado, konzentriert sich auf die Entwicklung chirurgischer Instrumente, die die Patientensicherheit und die chirurgische Leistung in verschiedenen minimal-invasiven Verfahren verbessern.
- Signed Master Services Agreement with Vicarious Surgical Inc.
- Opportunity to expand into the robotic surgery market
- Potential for increased revenue through design services
- Enhanced visibility and credibility in the medical device industry
- None.
BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray energy burns in minimally invasive surgery, today announced that Encision has signed a Master Services Agreement ("Agreement") with Vicarious Surgical Inc. ("Vicarious").
The Agreement commenced July 8, 2024 and will continue thereafter until terminated by certain actions of either party. Vicarious has contracted with Encision to provide certain related design services for elements of their robotic surgical system.
"We are happy to be teaming up with Vicarious to drive new levels of patient safety in robotic surgery. Working with Vicarious is an exciting opportunity for Encision to bring best in class technology to surgical robotics. Vicarious has world class leadership and vision and will change the face of robotic surgery. We are pleased to be able to contribute to that in a meaningful way and deliver patient safety and clinical performance to the best-in-class robotic platform. We welcome this next phase to our relationship," said Gregory J. Trudel, President and CEO of Encision.
Encision Inc. designs and markets a portfolio of high-performance surgical instrumentation that delivers advances in patient safety with AEM Technology, surgical performance, and value to hospitals across a broad range of minimally invasive surgical procedures. Based in Boulder, Colorado, the company pioneered the development and deployment of Active Electrode Monitoring, AEM technology, to eliminate dangerous stray energy burns during minimally invasive procedures. For additional information about all our products, please visit www.encision.com.
In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, the Company notes that statements in this press release and elsewhere that look forward in time, which include everything other than historical information, involve risks and uncertainties that may cause actual results to differ materially from those indicated by the forward-looking statements. Factors that could cause the Company's actual results to differ materially include, among others, its ability to develop new or enhanced products and have such products accepted in the market, its ability to increase net sales through the Company's distribution channels, its ability to compete successfully against other manufacturers of surgical instruments, insufficient quantity of new account conversions, insufficient cash to fund operations, delay in developing new products and receiving FDA approval for such new products and other factors discussed in the Company's filings with the Securities and Exchange Commission. Readers are encouraged to review the risk factors and other disclosures appearing in the Company's Annual Report on Form 10-K for the year ended March 31 2024 and subsequent filings with the Securities and Exchange Commission. We do not undertake any obligation to update publicly any forward-looking statements, whether as a result of the receipt of new information, future events, or otherwise.
CONTACT: Brandon Shepard, Encision Inc., 303-444-2600, bshepard@encision.com
SOURCE: Encision, Inc.
View the original press release on accesswire.com
FAQ
What is the significance of Encision's agreement with Vicarious Surgical for ECIA stock?
When did the Master Services Agreement between Encision and Vicarious Surgical begin?
What services will Encision (ECIA) provide to Vicarious Surgical under the new agreement?
How might this partnership impact Encision's (ECIA) position in the medical device industry?
